Insider · CIK 0001486373
Cole Douglas G.
Reports to the SEC for 10 companies · WATERTOWN, MA
Transactions
50
Companies
10
Filings
17
CIK
0001486373
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-24 | FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)A Award | +$114K |
| 2025-06-17 | FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award | +$120K |
| 2024-06-26 | FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)A Award | +$88.3K |
| 2024-06-06 | SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-06 | SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-08-11 | Sigilon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | −$3,413.907 |
| 2023-08-11 | Sigilon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | −$4,537.784 |
| 2023-06-21 | FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2023-06-08 | SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-01 | DNLIDenali Therapeutics Inc.A Award | — |
| 2023-06-01 | DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2023-05-19 | Sigilon Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-06-21 | FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)A Award | — |
| 2022-06-06 | SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-06-02 | DNLIDenali Therapeutics Inc.A Award | — |
| 2022-06-02 | DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2022-05-26 | Sigilon Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2021-07-13 | FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2021-06-24 | Sigilon Therapeutics, Inc.Stock Option (Right to Buy)A Award | +$88.6K |
| 2021-06-02 | DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2021-06-02 | DNLIDenali Therapeutics Inc.A Award | — |
| 2021-06-01 | DNLIDenali Therapeutics Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2021-06-01 | DNLIDenali Therapeutics Inc.M Exercise/Conversion | — |
| 2021-02-03 | SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-02-03 | SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-06-03 | DNLIDenali Therapeutics Inc. · Restricted Stock UnitsA Award | — |
| 2020-06-03 | DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2019-05-30 | DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2019-01-02 | QTRXQuanterix CorpA Award | — |
| 2019-01-02 | QTRXQuanterix Corp · Stock Option (Right to Buy)A Award | — |
| 2018-08-07 | QTRXQuanterix Corp · Stock Option (Right to Buy)A Award | — |
| 2018-08-07 | QTRXQuanterix CorpA Award | — |
| 2018-06-13 | DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2017-12-07 | DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2017-08-17 | EDITEditas Medicine, Inc.J Other | — |
| 2017-06-15 | EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award | — |
| 2016-08-11 | EDITEditas Medicine, Inc.J Other | — |
| 2016-08-10 | AGIOAGIOS PHARMACEUTICALS, INC.J Other | — |
| 2016-06-21 | AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)A Award | — |
| 2015-06-23 | AGIOAGIOS PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award | — |
| 2013-07-17 | Receptos, Inc.Stock Option (right to buy)A Award | — |
| 2013-03-25 | TETRAPHASE PHARMACEUTICALS INCNon-qualified Stock Option (right to buy)A Award | — |
| 2013-03-25 | TETRAPHASE PHARMACEUTICALS INCNon-qualified Stock Option (right to buy)A Award | — |
| 2011-05-16 | AVEO PHARMACEUTICALS, INC.S Sale | −$53.8K |
| 2011-05-16 | AVEO PHARMACEUTICALS, INC.S Sale | −$890K |
| 2011-05-13 | AVEO PHARMACEUTICALS, INC.S Sale | −$82.4K |
| 2011-05-13 | AVEO PHARMACEUTICALS, INC.S Sale | −$1.36M |
| 2011-05-12 | AVEO PHARMACEUTICALS, INC.S Sale | −$263K |
| 2011-05-12 | AVEO PHARMACEUTICALS, INC.S Sale | −$15.9K |
| 2011-03-17 | AVEO PHARMACEUTICALS, INC.C Conversion | — |
Recent filings
- 4Cole Douglas G.0001486373-26-000005SEC(opens sec.gov)
- 4Cole Douglas G.0001562180-25-004893SEC(opens sec.gov)
- 4/ACole Douglas G.0001562180-24-005718SEC(opens sec.gov)
- 4Cole Douglas G.0001562180-24-005358SEC(opens sec.gov)
- 4Cole Douglas G.0001562180-24-004840SEC(opens sec.gov)
- 4Cole Douglas G.0001415889-23-012136SEC(opens sec.gov)
- 4Cole Douglas G.0001562180-23-005479SEC(opens sec.gov)
- 4Cole Douglas G.0001562180-23-005027SEC(opens sec.gov)
- 4Cole Douglas G.0001714899-23-000093SEC(opens sec.gov)
- 4Cole Douglas G.0001415889-23-008492SEC(opens sec.gov)
- 4Cole Douglas G.0001562180-22-005318SEC(opens sec.gov)
- 4Cole Douglas G.0001562180-22-004942SEC(opens sec.gov)
- 4Cole Douglas G.0001714899-22-000095SEC(opens sec.gov)
- 4Cole Douglas G.0001415889-22-005826SEC(opens sec.gov)
- 4Cole Douglas G.0001562180-21-004932SEC(opens sec.gov)
- 4Cole Douglas G.0001415889-21-003236SEC(opens sec.gov)
- 4Cole Douglas G.0001209191-21-038374SEC(opens sec.gov)
Companies
- AGIOS PHARMACEUTICALS, INC.DirectorAGIO
- AVEO PHARMACEUTICALS, INC.Director
- Denali Therapeutics Inc.DirectorDNLI
- Editas Medicine, Inc.DirectorEDIT
- Foghorn Therapeutics Inc.DirectorFHTX
- Quanterix CorpDirectorQTRX
- Receptos, Inc.Director
- Sana Biotechnology, Inc.DirectorSANA
- Sigilon Therapeutics, Inc.Director
- TETRAPHASE PHARMACEUTICALS INCDirector
Address
99 COOLIDGE AVENUE STE 500
WATERTOWN, MA, 02472